Silk Road Medical Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Silk Road Medical Inc. (SILK) Tops Q1 EPS by 8c, Revenues Beat; Raises FY21 Revenue Guidance
May 4, 2021 5:25 PM EDTSilk Road Medical Inc. (NASDAQ: SILK) reported Q1 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.1 million versus the consensus estimate of $21.3 million.
Our first quarter results were characterized by meaningful progress on several commercial and operational... More
